GAGE12 mediates human gastric carcinoma growth and metastasis

International Journal of Cancer

Volumn 136, Issue 10, 2015, Pages 2284-2292

  Lee, Eun Kyung ^a,b   Song, Kyung A ^a,b   Chae, Ji Hye ^a   Kim, Kyoung Mee ^a,c   Kim, Seok Hyung ^a,b,c   Kang, Myung Soo ^a,b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

animal model; EMT; GAGE; gastric carcinoma; Krukenberg; MET; metastasis; orthotopic; ovary; stomach

Indexed keywords

CLAUDIN; CYTOKERATIN; HERMES ANTIGEN; OCCLUDIN; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VIMENTIN; GAGE7 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CARCINOMA CELL LINE; DISEASE ASSOCIATION; EPITHELIUM; GAGE12 GENE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME; METASTASIS; MOUSE; MOUSE MODEL; NONHUMAN; OVARY CARCINOMA; OVARY METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; STOMACH WALL; TUMOR GROWTH; TUMOR LOCALIZATION; ANIMAL; CANCER TRANSPLANTATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETICS; METABOLISM; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; SECONDARY; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84924303534     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29286     Document Type: Article

References (49)

1. Shridhar R, Almhanna K, Hoffe SE, et al. Increased survival associated with surgery and radiation therapy in metastatic gastric cancer: a surveillance, epidemiology, and end results database analysis. Cancer 2013; 119: 1636-42.
2. Ushijima T, Sasako M,. Focus on gastric cancer. Cancer Cell 2004; 5: 121-15.
3. Petru E, Pickel H, Heydarfadai M, et al. Nongenital cancers metastatic to the ovary. Gynecol Oncol 1992; 44: 83-6.
4. Hale RW,. Krukenberg tumor of the ovaries. A review of 81 records. Obstet Gynecol 1968; 32: 221-5.
5. Holtz F, Hart WR,. Krukenberg tumors of the ovary: a clinicopathologic analysis of 27 cases. Cancer 1982; 50: 2438-47.
6. Woodruff JD, Bie LS, Sherman RJ,. Mucinous tumors of the ovary. Obstet Gynecol 1960; 16: 699-712.
7. Novak P,. [Does the Krukenberg operation still have its justification?]. Hefte Unfallheilkd 1969; 100: 33-4.
8. Kuwabara Y, Yamada T, Yamazaki K, et al. Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis. Cancer Sci 2008; 99: 1933-9.
9. McClatchey AI,. Modeling metastasis in the mouse. Oncogene 1999; 18: 5334-9.
10. Kular RK, Yehiely F, Kotlo KU, et al. GAGE, an antiapoptotic protein binds and modulates the expression of nucleophosmin/B23 and interferon regulatory factor 1. J Interferon Cytokine Res 2009; 29: 645-55.
11. Cilensek ZM, Yehiely F, Kular RK, et al. A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, Interferon-gamma, taxol and gamma-irradiation. Cancer Biol Ther 2002; 1: 380-7.
12. Gjerstorff M, Burns JS, Nielsen O, et al. Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy. Am J Pathol 2009; 175: 314-23.
13. Gjerstorff MF, Johansen LE, Nielsen O, et al. Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy. Br J Cancer 2006; 94: 1864-73.
14. Kong U, Koo J, Choi K, et al. The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer. Hepatogastroenterology 2004; 51: 1519-23.
15. Cheung IY, Chi SN, Cheung NK,. Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma. Med Pediatr Oncol 2000; 35: 632-4.
16. Zambon A, Mandruzzato S, Parenti A, et al. MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia. Cancer 2001; 91: 1882-8.
17. Ku JL, Park JG,. Biology of SNU cell lines. Cancer Res Treat 2005; 37: 1-19.
18. Parker BD, Bankier A, Satchwell S, et al. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 1990; 179: 339-46.
19. Park JG, Yang HK, Kim WH, et al. Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 1997; 70: 443-9.
20. Nakatani H, Tahara E, Yoshida T, et al. Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel. Jpn J Cancer Res 1986; 77: 849-53.
21. McGill FM, Ritter DB, Rickard CS, et al. Krukenberg tumors: can management be improved? Gynecol Obstet Invest 1999; 48: 61-5.
22. Wang J, Shi YK, Wu LY, et al. Prognostic factors for ovarian metastases from primary gastric cancer. Int J Gynecol Cancer 2008; 18: 825-32.
23. Yada-Hashimoto N, Yamamoto T, Kamiura S, et al. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2003; 89: 314-17.
24. Prat J,. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas. Mod Pathol 2005; 18 (Suppl 2): S99-S111.
25. Takeichi M,. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-5.
26. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-52.
27. Darai E, Scoazec JY, Walker-Combrouze F, et al. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. Hum Pathol 1997; 28: 922-8.
28. Voutilainen KA, Anttila MA, Sillanpaa SM, et al. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. J Clin Pathol 2006; 59: 460-7.
29. Chang YT, Wu MS, Chang CJ, et al. Preferential loss of Fhit expression in signet-ring cell and Krukenberg subtypes of gastric cancer. Lab Invest 2002; 82: 1201-8.
30. Croce CM, Sozzi G, Huebner K,. Role of FHIT in human cancer. J Clin Oncol 1999; 17: 1618-24.
31. Negrini M, Monaco C, Vorechovsky I, et al. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 1996; 56: 3173-9.
32. Bar-Am I, Mor O, Yeger H, et al. Detection of amplified DNA sequences in human tumor cell lines by fluorescence in situ hybridization. Genes Chromosomes Cancer 1992; 4: 314-20.
33. Hara T, Ooi A, Kobayashi M, et al. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Lab Invest 1998; 78: 1143-53.
34. Park IC, Park MJ, Lee SH, et al. Increased susceptibility of the c-Myc overexpressing cell line, SNU-16, to TNF-alpha. Cancer Lett 1998; 125: 17-23.
35. Barretina J, Caponigro G, Stransky N, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603-7.
36. Ricciardelli C, Rodgers RJ,. Extracellular matrix of ovarian tumors. Semin Reprod Med 2006; 24: 270-82.
37. Tanner B, Hengstler JG, Luch A, et al. C-myc mRNA expression in epithelial ovarian carcinomas in relation to estrogen receptor status, metastatic spread, survival time, FIGO stage, and histologic grade and type. Int J Gynecol Pathol 1998; 17: 66-74.
38. Minata M, Kudo M, Harada KH, et al. Expression of e-cadherin and vascular endothelial growth factor in noncancerous liver is associated with recurrence of hepatocellular carcinoma after curative resection. Oncology 2013; 84 (Suppl 1): 88-92.
39. Jiang Z, Li C, Li F, et al. EGFR gene copy number as a prognostic marker in colorectal cancer patients treated with cetuximab or panitumumab: a systematic review and meta analysis. PLoS One 2013; 8: e56205.
40. Ishiwata T, Matsuda Y, Yamamoto T, et al. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation. Am J Pathol 2012; 180: 1928-41.
41. Sakuma K, Aoki M, Kannagi R,. Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition. Proc Natl Acad Sci USA 2012; 109: 7776-81.
42. Cosset E, Hamdan G, Jeanpierre S, et al. Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia. Blood 2011; 117: 1673-6.
43. Shang X, Lin X, Alvarez E, et al. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Neoplasia 2012; 14: 974-85.
44. Merikallio H, Kaarteenaho R, Paakko P, et al. Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins. J Clin Pathol 2011; 64: 136-40.
45. Killen MW, Taylor TL, Stults DM, et al. Configuration and rearrangement of the human GAGE gene clusters. Am J Transl Res 2011; 3: 234-42.
46. Gjerstorff MF, Besir H, Larsen MR, et al. Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapy. Protein Exp Purif 2010; 73: 217-22.
47. Zhang S, Zhou X, Yu H, et al. Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines. BMC Cancer 2010; 10: 163.
48. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-91.
49. Krivacic RT, Ladanyi A, Curry DN, et al. A rare-cell detector for cancer. Proc Natl Acad Sci USA 2004; 101: 10501-4.